Vaishali Pharma (NSE:VAISHALI) Debt-to-Equity : N/A (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Vaishali Pharma Debt-to-Equity?

Vaishali Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0.0 Mil. Vaishali Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0.0 Mil. Vaishali Pharma's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₹0.0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Vaishali Pharma's Debt-to-Equity or its related term are showing as below:

NSE:VAISHALI' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.34 Med: 0.8 Max: 7.43
Current: 0.34

During the past 11 years, the highest Debt-to-Equity Ratio of Vaishali Pharma was 7.43. The lowest was 0.34. And the median was 0.80.

NSE:VAISHALI's Debt-to-Equity is ranked worse than
54.04% of 842 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs NSE:VAISHALI: 0.34

Vaishali Pharma Debt-to-Equity Historical Data

The historical data trend for Vaishali Pharma's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaishali Pharma Debt-to-Equity Chart

Vaishali Pharma Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

Get a 7-Day Free Trial

0.80

0.79

0.36

Vaishali Pharma Quarterly Data
	Sep18	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															N/A	0.36	N/A	0.34	N/A

Competitive Comparison of Vaishali Pharma's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Vaishali Pharma's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vaishali Pharma's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vaishali Pharma's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Vaishali Pharma's Debt-to-Equity falls into.

Vaishali Pharma Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Vaishali Pharma's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(86.272	+	61.09)	/	405.319
	=	0.36

Vaishali Pharma's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0
	=	N/A

Vaishali Pharma (NSE:VAISHALI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Vaishali Pharma Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Vaishali Pharma's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaishali Pharma (NSE:VAISHALI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vaishali Pharma Ltd (NSE:VAISHALI) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

R.C. Patel Road, Off Sodawala Lane, 706-709, 7th Floor, Aravalli Business Center, Borivili (West), Mumbai, MH, IND, 400092

Website

http://www.vaishalipharma.com

Vaishali Pharma Ltd is a pharmaceutical company. The company is engaged in the business of trading (including exports) pharmaceuticals products. It mainly deals in Active Pharmaceutical Ingredient, pharmaceutical formulations, surgical products, Herbal and Nutraceutical Products, and veterinary supplements operating in the domestic and export market.

Vaishali Pharma (NSE:VAISHALI) Headlines

No Headlines